News

Sudden Cardiac Death: New Data Call Routine Prophylactic Defibrillator Use After Myocardial Infarction into Question

An analysis now published in the European Heart Journal, involving DZHK researchers, calls an established myocardial infarction therapy into question:…

Read more

DZHK Registry Shows How New Therapies Perform in Routine Clinical Practice

How does a new medicine perform once it is used in routine clinical practice following approval? This is the question the German Centre for…

Read more

Minimally Invasive Tricuspid Valve Repair Reduces Mortality and Hospitalisations

Study by the German Centre for Cardiovascular Research (DZHK), led by LMU University Hospital Munich, demonstrates for the first time benefits in hard…

Read more

From Cardiovascular Research to a Biotech Company: REVIER Therapeutics Launches with €6 Million

Heidelberg-based biotech company REVIER Therapeutics has officially launched. The company, which emerged from research conducted at the German Centre…

Read more

No Risk-Free Nicotine Use: International Research Team Maps the Biological Hierarchy Risks to the Cardiovascular System

A recent review led by University Medical Center Mainz compares the effects of cigarettes, waterpipes, heated tobacco products, e-cigarettes, and…

Read more

Obesity drug significantly reduces the risk of serious cardiovascular events and infections

People with type 2 diabetes and obesity may benefit from treatment with tirzepatide. Tirzepatide, marketed under the brand name Mounjaro, can reduce…

Read more

Detecting cardiomyopathies in the magnetic field

The MagMa study by the DHZC, involving DZHK researchers, shows for the first time in a prospective study that radiation-free magnetocardiography can…

Read more

4th DZG Munich Day 2026: Health Research in Munich Working Together for the Medicine of Tomorrow

Scientific highlights, transdisciplinary research, and new collaborations will be the focus of DZG Munich Day on July 29, 2026. For the fourth time,…

Read more

Cannabinoid receptor identified as new target against atherosclerosis

The so-called cannabinoid receptor was originally discovered because active compounds from the cannabis plant bind to it. In fact, however, it belongs…

Read more

Autoantibodies in focus: New study investigates cardiac and vascular damage in post-COVID ME/CFS

Why do some people develop persistent exertion intolerance with cardiovascular symptoms following a SARS-CoV-2 infection? A research team at the DZHK…

Read more